Targeted DNA/RNA Sequencing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Targeted DNA/RNA Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Targeted DNA/RNA Sequencing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Segment by Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.